Q6UN15 (FIP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 88.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Pre-mRNA 3'-end-processing factor FIP1 Short name=hFip1 Alternative name(s): FIP1-like 1 protein Factor interacting with PAP Rearranged in hypereosinophilia | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 594 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. FIP1L1 contributes to poly(A) site recognition and stimulates poly(A) addition. Binds to U-rich RNA sequence elements surrounding the poly(A) site. May act to tether poly(A) polymerase to the CPSF complex. Ref.1 |
| Subunit structure | Component of the cleavage and polyadenylation specificity factor (CPSF) complex, composed of CPSF1, CPSF2, CPSF3, CPSF4 and FIP1L1. Found in a complex with CPSF1, FIP1L1 and PAPOLA. Interacts with CPSF1, CPSF4, CSTF2, CSTF3 and PAPOLA. Ref.1 |
| Subcellular location | |
| Involvement in disease | A chromosomal aberration involving FIP1L1 is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del4(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-PDGFRA). Ref.7 Ref.9 |
| Sequence similarities | Belongs to the FIP1 family. |
| Sequence caution | The sequence AAH24016.1 differs from that shown. Reason: Intron retention. The sequence AAH52959.1 differs from that shown. Reason: Intron retention. |
Ontologies
| Keywords | |
|---|---|
| Biological process | mRNA processing |
| Cellular component | Nucleus |
| Coding sequence diversity | Alternative splicing |
| Ligand | RNA-binding |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | mRNA processing Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular_component | mRNA cleavage and polyadenylation specificity factor complex Inferred from electronic annotation. Source: Compara nucleusInferred from direct assay. Source: HPA |
| Molecular_function | RNA binding Inferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q6UN15-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 3 (identifier: Q6UN15-3) The sequence of this isoform differs from the canonical sequence as follows: 29-43: Missing. 213-235: Missing. 272-307: Missing. | ||||||
| Isoform 4 (identifier: Q6UN15-4) The sequence of this isoform differs from the canonical sequence as follows: 29-43: Missing. 393-393: F → K 394-594: Missing. | ||||||
| Isoform 5 (identifier: Q6UN15-5) The sequence of this isoform differs from the canonical sequence as follows: 29-43: Missing. 389-389: P → PPPGIPITVP | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 594 | 594 | Pre-mRNA 3'-end-processing factor FIP1 | PRO_0000215037 | |||||
Regions | |||||||||
| Region | 1 – 356 | 356 | Necessary for stimulating PAPOLA activity | ||||||
| Region | 1 – 111 | 111 | Sufficient for interaction with PAPOLA | ||||||
| Region | 137 – 243 | 107 | Sufficient for interaction with CPSF4 | ||||||
| Region | 443 – 594 | 152 | Sufficient for interaction with CPSF1 and CSTF3 | ||||||
| Compositional bias | 356 – 406 | 51 | Pro-rich | ||||||
| Compositional bias | 456 – 562 | 107 | Arg-rich | ||||||
| Compositional bias | 478 – 594 | 117 | Glu-rich | ||||||
Sites | |||||||||
| Site | 339 – 340 | 2 | Breakpoint for interstitial deletion to form the FIP1L1-PDGFRA fusion protein | ||||||
Amino acid modifications | |||||||||
| Modified residue | 85 | 1 | Phosphoserine Ref.13 Ref.15 Ref.18 | ||||||
| Modified residue | 87 | 1 | Phosphoserine Ref.13 Ref.15 Ref.18 | ||||||
| Modified residue | 89 | 1 | Phosphoserine Ref.13 Ref.15 | ||||||
| Modified residue | 259 | 1 | Phosphoserine Ref.13 Ref.17 Ref.18 | ||||||
| Modified residue | 294 | 1 | N6-acetyllysine Ref.16 | ||||||
| Modified residue | 304 | 1 | Phosphoserine Ref.17 Ref.18 | ||||||
| Modified residue | 426 | 1 | Phosphotyrosine Ref.10 | ||||||
| Modified residue | 492 | 1 | Phosphoserine Ref.13 Ref.15 Ref.17 Ref.18 | ||||||
| Modified residue | 494 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 496 | 1 | Phosphoserine Ref.13 Ref.15 Ref.18 | ||||||
| Modified residue | 500 | 1 | Phosphoserine Ref.11 Ref.13 Ref.15 | ||||||
| Modified residue | 554 | 1 | Phosphoserine Ref.14 Ref.17 | ||||||
Natural variations | |||||||||
| Alternative sequence | 29 – 43 | 15 | Missing in isoform 3, isoform 4 and isoform 5. | VSP_016728 | |||||
| Alternative sequence | 213 – 235 | 23 | Missing in isoform 3. | VSP_016729 | |||||
| Alternative sequence | 272 – 307 | 36 | Missing in isoform 3. | VSP_016730 | |||||
| Alternative sequence | 389 | 1 | P → PPPGIPITVP in isoform 5. | VSP_046213 | |||||
| Alternative sequence | 393 | 1 | F → K in isoform 4. | VSP_016731 | |||||
| Alternative sequence | 394 – 594 | 201 | Missing in isoform 4. | VSP_016732 | |||||
Experimental info | |||||||||
| Sequence conflict | 118 | 1 | V → I in BAG58575. Ref.3 | ||||||
| Sequence conflict | 312 | 1 | G → R in AAH24016. Ref.6 | ||||||
| Sequence conflict | 312 | 1 | G → R in AAH52959. Ref.6 | ||||||
| Sequence conflict | 524 | 1 | K → R in AAH52959. Ref.6 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase." Kaufmann I., Martin G., Friedlein A., Langen H., Keller W. EMBO J. 23:616-626(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION IN PRE-MRNA 3'-END PROCESSING, IDENTIFICATION IN THE CPSF COMPLEX, IDENTIFICATION IN A COMPLEX WITH CPSF1 AND PAPOLA, INTERACTION WITH CPSF1; CPSF4; CSTF2; CSTF3 AND PAPOLA, RNA-BINDING, IDENTIFICATION BY MASS SPECTROMETRY. Tissue: Testis. |
| [2] | "Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs." Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S., Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W., Ottenwaelder B., Obermaier B. Poustka A.Genome Res. 11:422-435(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Uterus. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5). Tissue: Hippocampus. |
| [4] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4). Tissue: Brain, Eye, Placenta and Testis. |
| [7] | "Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome." Griffin J.H., Leung J., Bruner R.J., Caligiuri M.A., Briesewitz R. Proc. Natl. Acad. Sci. U.S.A. 100:7830-7835(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-339, DISEASE, IDENTIFICATION BY MASS SPECTROMETRY OF THE FIP1L1-PDGFRA FUSION PROTEIN. Tissue: Eosinophil. |
| [8] | "A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein." Zhao X., Oeberg D., Rush M., Fay J., Lambkin H., Schwartz S. J. Virol. 79:4270-4288(2005) [PubMed] [Europe PMC] [Abstract] Cited for: RNA-BINDING. |
| [9] | "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome." Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., Kutok J., Clark J., Galinsky I., Griffin J.D., Cross N.C., Tefferi A., Malone J., Alam R., Schrier S.L., Schmid J., Rose M., Vandenberghe P. Gilliland D.G.N. Engl. J. Med. 348:1201-1214(2003) [PubMed] [Europe PMC] [Abstract] Cited for: DISEASE. |
| [10] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-426, MASS SPECTROMETRY. |
| [11] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-87; SER-89; SER-259; SER-492; SER-496 AND SER-500, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554, MASS SPECTROMETRY. Tissue: Liver. |
| [15] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-87; SER-89; SER-492; THR-494; SER-496 AND SER-500, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [16] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-294, MASS SPECTROMETRY. |
| [17] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259; SER-304; SER-492 AND SER-554, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-87; SER-259; SER-304; SER-492 AND SER-496, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AY366510 mRNA. Translation: AAQ88277.1. AL136910 mRNA. Translation: CAB66844.1. AK295737 mRNA. Translation: BAG58575.1. AC058822 Genomic DNA. No translation available. AC095040 Genomic DNA. No translation available. AC098587 Genomic DNA. No translation available. AC098821 Genomic DNA. No translation available. AC105384 Genomic DNA. No translation available. AC110298 Genomic DNA. No translation available. AC110792 Genomic DNA. No translation available. AC124017 Genomic DNA. No translation available. AC138607 Genomic DNA. No translation available. AC138779 Genomic DNA. No translation available. CH471057 Genomic DNA. Translation: EAX05448.1. BC011543 mRNA. Translation: AAH11543.1. BC017724 mRNA. Translation: AAH17724.1. BC024016 mRNA. Translation: AAH24016.1. Sequence problems. BC052959 mRNA. Translation: AAH52959.1. Sequence problems. BC110383 mRNA. Translation: AAI10384.1. AY229892 mRNA. Translation: AAP69563.1. Different termination. |
| IPI | IPI00008449. IPI00395337. IPI00658114. IPI00965581. |
| RefSeq | NP_001128409.1. NM_001134937.1. NP_001128410.1. NM_001134938.1. NP_112179.2. NM_030917.3. |
| UniGene | Hs.624245. |
3D structure databases | |
| ProteinModelPortal | Q6UN15. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-42503N. |
| IntAct | Q6UN15. 6 interactions. |
| MINT | MINT-1475441. |
| STRING | 9606.ENSP00000336752. |
PTM databases | |
| PhosphoSite | Q6UN15. |
Polymorphism databases | |
| DMDM | 74749365. |
Proteomic databases | |
| PaxDb | Q6UN15. |
| PeptideAtlas | Q6UN15. |
| PRIDE | Q6UN15. |
Protocols and materials databases | |
| DNASU | 81608. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000306932; ENSP00000302993; ENSG00000145216. ENST00000337488; ENSP00000336752; ENSG00000145216. ENST00000358575; ENSP00000351383; ENSG00000145216. ENST00000507166; ENSP00000423325; ENSG00000145216. ENST00000507922; ENSP00000425456; ENSG00000145216. |
| GeneID | 81608. |
| KEGG | hsa:81608. |
| UCSC | uc003gzx.4. human. uc003gzy.3. human. uc003gzz.3. human. |
Organism-specific databases | |
| CTD | 81608. |
| GeneCards | GC04P054159. |
| HGNC | HGNC:19124. FIP1L1. |
| HPA | HPA037475. |
| MIM | 607685. phenotype. 607686. gene. |
| neXtProt | NX_Q6UN15. |
| Orphanet | 3260. Idiopathic hypereosinophilic syndrome. |
| PharmGKB | PA134875694. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG5213. |
| HOVERGEN | HBG059889. |
| InParanoid | Q6UN15. |
| KO | K14405. |
| OMA | GNNIQVI. |
| OrthoDB | EOG4S4PGB. |
| PhylomeDB | Q6UN15. |
Gene expression databases | |
| ArrayExpress | Q6UN15. |
| Bgee | Q6UN15. |
| CleanEx | HS_FIP1L1. |
| Genevestigator | Q6UN15. |
| GermOnline | ENSG00000145216. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR007854. Fip1. [Graphical view] |
| Pfam | PF05182. Fip1. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | FIP1L1. human. |
| GenomeRNAi | 81608. |
| NextBio | 71928. |
| PMAP-CutDB | Q6UN15. |
| SOURCE | Search... |
Entry information
| Entry name | FIP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q6UN15 Secondary accession number(s): B4DIR3 Q9H077 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
